Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2020
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2020
- Period start
- 1 Jan 2020
- Submitted date
- 25 Jun 2021
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 353,107 |
| Balance sheet | Cash and cash equivalents | 50,155 |
| Balance sheet | Current assets | 134,445 |
| Balance sheet | Current liabilities | 169,198 |
| Balance sheet | Equity | 140,914 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 218,662 |
| Balance sheet | Non-current liabilities | 42,995 |
| Balance sheet | Retained earnings (loss) from previous periods | 97,523 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -24,023 |
| Income statement scheme 1 | Labour costs | -316,976 |
| Income statement scheme 1 | Revenue | 786,521 |
| Income statement scheme 1 | Annual period profit / loss | 40,641 |
| Income statement scheme 1 | Operating profit (loss) | 56,924 |
| Income statement scheme 1 | Profit (loss) before income tax | 40,641 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 97,523 |
| Note: Labour costs | Employees | 13 |
| Note: Labour costs | Labour costs | 316,976 |
Linked company
Company: Asper Biogene OÜ